This stability eliminates the need for protective carriers that other growth factors require
2002;348:93112 Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF
Studies show it activates fibroblasts the skin cells responsible for producing collagen, elastin, and glycosaminoglycans leading to measurably firmer, more resilient skin over time
A commonly used protocol involves administration five times per week for approximately eight weeks, followed by a two-week break before repeating the cycle, if appropriate
Key Takeaways Injectable GHK-Cu is not FDA-approved: do not treat research-use GHK-Cu like a prescribed medication
The FEBS Journal , 282 (8), 14681480